Implications of recent heart failure trials for patients with hypertension |
| |
Authors: | Poole-Wilson P A |
| |
Affiliation: | (1) Department of Cardiac Medicine, National Heart and Lung Institute, Imperial College, Dovehouse Street, SW3 7AG London, England |
| |
Abstract: | There are two major reasons why hypertension is an important risk factor for heart failure. The first is that an elevated blood pressure increases the wall stress in the left ventricle. The second is that hypertension, in a complex manner, contributes to the development of atheromatous vascular disease. Among the more common causes of heart failure are the sequelae of coronary heart disease. The treatment of hypertension modifies the progression to heart failure and the occurrence of coronary events. In patients who have heart failure, hypotension rather than hypertension is a predictor of a poor outcome, likely because low blood pressure is a consequence of damage to the myocardium. The clinical message is that hypertension should be treated aggressively. Where heart failure is a likely outcome, or where hypertension occurs in the presence of heart failure, there is a strong case for using drugs that have been shown to be beneficial in the treatment of both hypertension and heart failure. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|